Hosted on MSN1mon
ATS signals Q4 revenue range of $650M-$710M amid strong life sciences backlog growthCEO Andrew Hider remarked that mid- to long-term, ATS's ability to build and support operations regionally is seen as a strategic strength. Patrick Baumann, J.P. Morgan: Inquired about backlog ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results